Gerecht-Nir Sharon, Itskovitz-Eldor Joseph
Biotechnology Interdisciplinary Unit, Technion - Israel Institute of Technology, Haifa.
Transpl Immunol. 2004 Apr;12(3-4):203-9. doi: 10.1016/j.trim.2003.12.013.
Cell therapy refers to the transplantation of healthy, functional and propagating cells to restore the viability or function of deficient tissues. Stem cells are characterized by self-renewal and the potential to form differentiated cells. In early mammalian embryos, at the blastocyst stage, the inner cell mass is pluripotent. Thus, it has been recognized that human embryonic stem cells (hESCs), which are derived from such cells of blastocysts, may serve as a source of numerous types of differentiated cells. The first part of this review summarizes different techniques for the derivation and maintenance of undifferentiated hESCs. In the second part, issues concerning the safety and bulk production, which may enable hESCs use in future clinical applications, are presented. The last part of this review details accumulated data regarding the in vitro differentiation potential of hESCs.
细胞疗法是指移植健康、有功能且能增殖的细胞,以恢复受损组织的活力或功能。干细胞的特征是自我更新以及具有形成分化细胞的潜力。在早期哺乳动物胚胎的囊胚阶段,内细胞团是多能的。因此,人们已经认识到,源自囊胚此类细胞的人类胚胎干细胞(hESCs)可能成为多种分化细胞的来源。本综述的第一部分总结了未分化hESCs的分离和维持的不同技术。第二部分介绍了有关安全性和大规模生产的问题,这些问题可能使hESCs在未来临床应用中得以使用。本综述的最后一部分详细阐述了关于hESCs体外分化潜力的累积数据。